Literature DB >> 22057402

Use of intrathecal clonidine in patients with multiple sclerosis or spastic paraparesis.

Joseph K Ho, Saud A Sadiq.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057402     DOI: 10.1007/s00415-011-6290-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Response of intrathecal baclofen resistance to dose reduction.

Authors:  Joanna A Cooper; Barbara Ridley
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

Review 2.  Intrathecal baclofen in multiple sclerosis: too little, too late?

Authors:  April Erwin; Mark Gudesblatt; Francois Bethoux; Susan E Bennett; Stephen Koelbel; Robert Plunkett; Saud Sadiq; Valerie L Stevenson; Ann-Marie Thomas; Carlo Tornatore; Mauro Zaffaroni; Mary Hughes
Journal:  Mult Scler       Date:  2011-01-31       Impact factor: 6.312

3.  Long-term intrathecal baclofen therapy in ambulatory patients with spasticity.

Authors:  Saud A Sadiq; Gary C Wang
Journal:  J Neurol       Date:  2005-11-22       Impact factor: 4.849

4.  Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity.

Authors:  S A Sadiq; C A Poopatana
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

Review 5.  alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995).

Authors:  J C Eisenach; M De Kock; W Klimscha
Journal:  Anesthesiology       Date:  1996-09       Impact factor: 7.892

6.  Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study.

Authors:  J W Middleton; P J Siddall; S Walker; A R Molloy; S B Rutkowski
Journal:  Arch Phys Med Rehabil       Date:  1996-08       Impact factor: 3.966

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.